Digipharm secures new strategic investment

Digipharm helps patients access the best available healthcare with its pioneering value-based contracting platform. The independent platforms provide manufacturers, payers and healthcare providers with the ability to automate and execute value-based reimbursement agreements.

Since patient data and patient outcomes are used to determine the cost of care, Digipharm uses blockchain technology to create a medical information infrastructure that enables trust and a synchronized overview of these outcomes for all contracting parties. Digipharm’s smart contracts also remove the administrative burden of tracking and executing these agreements.

After the recent partnership agreement with Roche and NHS Wales, Digipharm has attracted UAE-based Gawah Holdings Inc. to invest in the company. Gowah, a multi-industry focused investment holding company with interests across the globe but primarily focused on the MENA region, is taking strategic equity in the startup and in return, the latter will implement its proprietary value-based healthcare solutions across the GCC beginning with the United Arab Emirates.

“We are extremely thrilled to begin our journey with Gawah Holdings given the intellectual capital, background in healthcare at the group & resources that Digipharm can extract from. The most recent announcements out of the United Arab Emirates around blockchain, crypto & defi plus the regulatory friendliness & focus on healthcare make it the perfect place for us to expand our efforts into the region. What Digipharm is building shall be a critical foundation for future health systems that enables us to thrive and implement key principles that encourage cost-effectiveness throughout the care continuum. We believe this is something that the region too is focused on and the United Arab Emirates & GCC will be an exemplar that the rest of the world can learn from” said Ahmed Abdulla, CEO of Digipharm ltd.

(Press release/RAN)